Report Code: A12351 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Pharmaceutical Suspension Market
Request Now !A pharmaceutical suspension is a dispersion of insoluble particles in a liquid medium. Pharmaceutical suspensions form a crucial class of pharmaceutical dosage forms. Various advantages of pharmaceutical suspensions include effective dispensing of different hydrophobic drugs, masking unpleasant taste of some ingredients, offering resistance to drug degradation due to oxidation, hydrolysis or microbial activity, efficient intramuscular depot therapy, and easy swallowing for pediatric and geriatric patients. In addition, pharmaceutical suspensions can incorporate a higher concentration of drugs than solution dosage forms.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.
However, with COVID-19 the supply chain of raw materials required to manufacture pharmaceutical suspensions has been disrupted in many countries. In addition, the market growth of pharmaceuticals is declining, as manufacturers of drugs have slowed down their production due to the pandemic. This, in turn, is expected to have a significant impact on the pharmaceutical suspension market.
Top Impacting Factors
Suspensions are usually made with the drugs such as prednisolone that are insoluble or poorly soluble in aqueous solutions. This helps them get properly delivered to the target site. Suspensions can help with the absorption of such drugs, which is a key factor positively influencing the growth of the market.
Suspensions can be used for a topical application. This is the case with the calamine solutions. With a rise in cases with dermatological issues, the use of calamine lotions has increased. Therefore, this factor has further contributed toward the growth of the pharmaceutical suspension market.
In addition, pharmaceutical suspensions are prepared to mask the unpleasant or bitter taste of drugs. Drugs formulated in suspensions are more palatable. With this, pediatricians can easily prescribe drugs to children. Hence, this factor is augmenting the growth of the pharmaceutical suspension market.
However, the formulation of pharmaceutical suspensions is bulky and difficult to formulate. In addition, sedimentation of suspensions can occur while handling. These factors together impede the growth of the pharmaceutical suspension market.
Key Market Trends
The hospital segment is anticipated to garner a large share in the pharmaceutical suspension market, owing to the significant number of inpatient and outpatient visits and the requirement of a large volume of drugs, which often include pharmaceutical suspensions to cater during the treatment process.
North America is expected to lead the pharmaceutical suspension market. This can be attributed to the region's rising prevalence of chronic diseases and the presence of key players in the pharmaceutical suspension market.
Key players of the global pharmaceutical suspension market are focusing on extending their product portfolios and increasing the number of their pharmaceutical suspension manufacturing facilities.
Asia Pacific is expected to hold a major share of the pharmaceutical suspension market during the forecast period, owing to increasing number of pediatric patients who are often being prescribed syrups in the form of suspensions.
Key Benefits of the Report
Questions Answered in the Pharmaceutical Suspension Report
Pharmaceutical Suspension Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Proportion of Solid Particles |
|
By Electrokinetic Nature |
|
By Size of Solid Particles |
|
By End User |
|
By Region |
|
Key Market Players | 3M Company, Becton, Dickinson and Company, Novartis AG, Bayer AG, Pfizer, Inc., Johnson and Johnson, Inc., Antares Pharma, Inc. , F. Hoffman-La Roche, Merck and Co., Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd |
Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers